i.lehtinen

TL2 · Kochi

Contributes reviews on supplier material. Based in Kochi.

Joined 30 September 2024 · last posted 3d

84 posts, newest first. Showing up to 150.

What to bring: records that a clinician can actually use — a second dataset Replied, post #75 · Clinical › Prescriber conversations · 25 Jul 2026 · 0 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #26 · Analytics › Home & field testing · 23 Jul 2026 · 18 likes My experience of Cost versus information contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is…
Restarting after a long gap: what the labelling implies Replied, post #36 · Practice › Dosing & titration · 21 Jul 2026 · 15 likes Research-use-only material is not a licensed product and no labelling covers it. Everything in this subcategory about published schedules describes what was done in…
Follow-up: Signs of dehydration worth acting on Replied, post #22 · Safety › Adverse events · 12 Jul 2026 · 0 likes I disagree with the framing of Signs of dehydration worth acting above, and I think it is a substantive disagreement rather than a terminological one. Setting out why,…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #56 · Compounds › Retatrutide · 12 Jul 2026 · 14 likes Post #54 is right about the mechanism and I think understates the practical bit. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this…
The anatomy of a question that gets answered within an hour Replied, post #109 · Start Here › How to Ask · 12 Jul 2026 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
Why we ask for units every single time, with three examples of what goes wrong Replied, post #119 · Start Here › How to Ask · 11 Jul 2026 · 1 like That is clearer than the version I had in my head. Thank you.
Tracking intake honestly when appetite is absent Replied, post #89 · Nutrition & Training › Protein & intake · 7 Jul 2026 · 28 likes Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once.
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #53 · Analytics › Impurities & related substances · 6 Jul 2026 · 27 likes Taking post #51 at face value and following it one step further. Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide.…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #67 · Analytics › Home & field testing · 5 Jul 2026 · 1 like Source for the Lateral-flow and colorimetric approaches figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version…
Selection into a registry and what it does to the estimate — a second dataset Replied, post #7 · Evidence › Study critique · 4 Jul 2026 · 18 likes Statistical significance and clinical importance are different and both are needed. A significant difference below the minimal important difference is a real finding of…
Racemisation and why it is invisible to a mass measurement Replied, post #126 · Analytics › Impurities & related substances · 15 Jun 2026 · 0 likes Racemisation came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
Documenting a payment dispute without naming and shaming — the long version Replied, post #3 · Sourcing › Payments · 13 Jun 2026 · 32 likes The site does not carry prices, payment details or transaction routes, and questions asking for them will be answered with that rather than with a link. I would be…
Fixed versus detachable needles: the trade-offs — does this still hold? Replied, post #6 · Devices › Syringes & needles · 4 Jun 2026 · 7 likes A detachable luer needle plus hub can retain enough volume to matter. Whether it matters to you depends on your dose, and the arithmetic is worth doing once. Nothing…
Transporting a vial for a weekend away — a second dataset Replied, post #72 · Practice › Storage & stability · 4 Jun 2026 · 8 likes Light protection is easy and cheap. The original carton exists for a reason and a vial stored in it is protected without anybody having to think about it again. I…
Conditions that change the calculus rather than forbidding it Replied, post #18 · Safety › Contraindications · 28 May 2026 · 6 likes Where a contraindication is relative rather than absolute, the reasoning usually appears in the assessment report rather than the labelling.
Why fasting instructions for oral semaglutide are not optional advice Replied, post #16 · Compounds › Oral incretins · 26 May 2026 · 17 likes Taking the oral product with more water than instructed reduces absorption rather than helping it. That is counter-intuitive and it is one of the few dosing…
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #40 · Analytics › COA interpretation · 5 May 2026 · 4 likes That matches what I have seen, for whatever a single anecdote is worth.
The "under review" status pill and when a moderator applies it Replied, post #93 · Evidence › Preprints · 24 Apr 2026 · 5 likes Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for a fast-moving question and it should be an explicit one. If…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #5 · Analytics › Home & field testing · 19 Apr 2026 · 4 likes Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative…
The "under review" status pill and when a moderator applies it Replied, post #72 · Evidence › Preprints · 14 Apr 2026 · 12 likes Bookmarking this. I will come back when I have something worth adding.
Revisiting: Drawing up with one needle and injecting with another Replied, post #38 · Practice › Administration · 4 Apr 2026 · 0 likes On post #34 — agreed on the reasoning, with one qualification. Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after…
Personal import allowances, compared — a second dataset Replied, post #95 · Access › International · 31 Mar 2026 · 0 likes Building on post #92 rather than restating it. Both are useful and they are different contributions. A first-hand account and a citation answer different halves of the…
Where impurities in solid-phase peptide synthesis come from Replied, post #54 · Analytics › Impurities & related substances · 29 Mar 2026 · 10 likes Saving this. It is the version I will quote when the question comes round again.
Open-label extensions: what survives and what does not Replied, post #3 · Evidence › Trials · 25 Mar 2026 · 5 likes Building on the opening post rather than restating it. Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses…
Contributing data without breaching anyone's privacy Replied, post #71 · Data & Tools › Datasets · 6 Mar 2026 · 3 likes Post #68 is right about the mechanism and I think understates the practical bit. Reproducibility: if sharing data, include enough context (compound, dose, timeframe,…
Reading an interaction checker output critically Replied, post #136 · Practice › Interactions · 4 Mar 2026 · 4 likes Absence of an interaction study is not evidence of no interaction. A great many combinations discussed here have simply never been studied, and saying so is more useful…
Whether protein timing matters at a large deficit Replied, post #24 · Nutrition & Training › Protein & intake · 10 Feb 2026 · 31 likes Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant sources require higher volume. Neither is nutritionally…
Heterogeneity as information rather than as a nuisance Replied, post #86 · Evidence › Meta-analyses · 2 Feb 2026 · 1 like Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
Specification in the result column: why that is a meaningful error Replied, post #115 · Analytics › COA interpretation · 1 Feb 2026 · 0 likes Narrowing post #112, because the general version has more than one answer. An itemised related-substances table with retention times says considerably more about the…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #62 · Sourcing › Red flags · 24 Jan 2026 · 2 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
Preprint servers and what screening they do Replied, post #22 · Evidence › Preprints · 12 Jan 2026 · 9 likes Where numbers change between preprint and published version, the changes are not random. They tend toward a smaller effect and a more carefully hedged claim.
Revisiting: Language barriers in accessing a prescription abroad Replied, post #51 · Access › International · 12 Jan 2026 · 12 likes That reframing is the whole thing. The facts I already had.
Pre-registering a personal experiment, seriously — a second dataset Replied, post #18 · Research Methods › N-of-1 designs · 7 Jan 2026 · 31 likes Reading back through the Pre-registering a personal experiment threads from last year, the same three questions come up every time and only one of them has ever been…
Vomiting: when it is expected and when it is a reason to stop Replied, post #52 · Practice › Side effects · 28 Dec 2025 · 32 likes Adding the measurement that post #49 says would settle it. The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence…
DXA precision and the least significant change for lean mass Replied, post #39 · Outcomes › Body composition · 3 Dec 2025 · 18 likes Post #35 and I disagree about the size of the effect, not about the direction. The bit of DXA precision that nobody enjoys is that the answer changes depending on what…
Interpreting a result that disagrees with the supplier's certificate Replied, post #15 · Sourcing › Independent verification · 17 Nov 2025 · 0 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. Two people can read the same figure differently…
How to read a forest plot, properly, from scratch Replied, post #56 · Evidence › Trials · 16 Nov 2025 · 18 likes I had written a reply contradicting post #55 and deleted it. Here is what survived. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio…
The anatomy of a question that gets answered within an hour — the long version Replied, post #85 · Start Here › How to Ask · 11 Nov 2025 · 0 likes A question about somebody else's post should be a reply to that post, not a new topic. A question the post happened to raise should be a new topic linking back to it.…
Where to report an adverse event officially, by region — a second dataset Replied, post #88 · Safety › Adverse events · 3 Nov 2025 · 0 likes I read post #85 twice before replying, because I had assumed the opposite. Medullary thyroid carcinoma is the reason these compounds are contraindicated in people with…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #21 · Clinical › Special populations · 29 Oct 2025 · 0 likes Adding the boring version of older adults, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations, in…
Where to report an adverse event officially, by region — a second dataset Replied, post #63 · Safety › Adverse events · 27 Oct 2025 · 18 likes The arithmetic in post #60 is right; the assumption feeding it is the part to check. Where a member describes something concerning, escalating the thread rather than…
An orphaned page with no inbound links — the long version Replied, post #14 · Meta › Wiki maintenance · 10 Oct 2025 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #53 · Compounds › Secretagogues & GH axis · 29 Sep 2025 · 0 likes Post #49 describes the usual case. This is about the unusual one. Speaking only to reading a rodent study as I have actually seen it, rather than as it is usually…
Specification in the result column: why that is a meaningful error Replied, post #47 · Analytics › COA interpretation · 21 Sep 2025 · 0 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #118 · Data & Tools › Datasets · 10 Sep 2025 · 0 likes Where a dataset is used to support a claim in a maintained document, the version used should be cited. Otherwise the document and the data drift apart silently.
About the Home & field testing category Replied, post #4 · Analytics › Home & field testing · 31 Aug 2025 · 0 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #54 · Evidence › Journal club · 18 Aug 2025 · 8 likes I would put moderate confidence on the mainstream reading of STEP 4 and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
Reconciling a label claim with a content assay Replied, post #2 · Analytics › COA interpretation · 8 Aug 2025 · 4 likes Reading back through, this was answered upthread and I missed it. My fault.
What this community means by "a source", in practical terms Replied, post #57 · Start Here › Welcome · 3 Aug 2025 · 4 likes Understood. Thank you for being specific about the limits of it.
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #27 · Sourcing › Vendor reports · 19 Jul 2025 · 0 likes On vendor documentation pages: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than…
Coming back to: Official shortage notices and what they authorise Replied, post #48 · Access › Shortages · 5 Jul 2025 · 20 likes Picking up post #47: that is the part I would want checked first. Where an alternative within the class is available, the comparison is a clinical one and the doses are…
Repeatability versus intermediate precision Replied, post #48 · Analytics › Method validation · 23 Jun 2025 · 16 likes Picking up post #46: that is the part I would want checked first. The most useful single question about a method: what would it fail to detect? Every method has an…
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #147 · Compounds › Cagrilintide & amylin analogues · 19 Jun 2025 · 7 likes The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The trade-off of a fixed combination is that you cannot titrate the…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #21 · Practice › Reconstitution · 13 Jun 2025 · 9 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
Why plausible mechanism is not evidence of effect — one year on Replied, post #5 · Compounds › Repair & healing peptides · 5 Jun 2025 · 22 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
Validating a calculator against hand arithmetic — what changed since Replied, post #76 · Data & Tools › Calculators · 18 May 2025 · 2 likes Post #75 answers the question as asked. The question underneath it is different. I think the Validating a calculator against hand question is answerable and has not…
Coverage for the indication versus for the drug Replied, post #64 · Access › Insurance & coverage · 13 May 2025 · 13 likes Adding a note of thanks rather than an opinion. I did not know most of that.
An orphaned page with no inbound links Replied, post #34 · Meta › Wiki maintenance · 29 Apr 2025 · 2 likes I read post #32 twice before replying, because I had assumed the opposite. Flagging a stale cross-reference. This page links to a topic that was later promoted into its…
Retatrutide dose escalation in the published trials Replied, post #160 · Compounds › Retatrutide · 20 Apr 2025 · 5 likes No phase 3 results exist for retatrutide. Anything attributed to a completed phase 3 trial of this compound is either a misreading or an invention, and the honest…
Certificates issued by the seller versus by a laboratory Replied, post #44 · Analytics › COA interpretation · 14 Apr 2025 · 19 likes Where I part company with post #42, and it is a narrow parting. The distinction between release testing and characterisation is one industrial documents make and retail…
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #11 · Evidence › Journal club · 25 Mar 2025 · 10 likes On retatrutide phase 2 obesity paper, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the…
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #122 · Compounds › Semaglutide · 6 Mar 2025 · 15 likes This follows post #119 rather than contradicting it. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in…
Coming back to: An 18-month record including the parts that went badly Replied, post #24 · Outcomes › Progress reports · 6 Mar 2025 · 0 likes Counterpoint on 18-month record, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #31 · Compounds › Tirzepatide · 2 Mar 2025 · 19 likes Post #30 is the version of this I will quote in future. One addition. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent…
Consistent declarations and why they matter more than clever ones Replied, post #18 · Sourcing › Logistics · 11 Feb 2025 · 4 likes I had written a reply contradicting post #14 and deleted it. Here is what survived. Counterpoint on consistent declarations, offered without confidence: the same…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #30 · Evidence › Meta-analyses · 31 Jan 2025 · 4 likes Answering the question post #26 raises rather than the one it answers. Summarising the Random versus fixed effects thread so far, since it is long and the answer is…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #87 · Analytics › COA interpretation · 30 Jan 2025 · 1 like Where I part company with post #86, and it is a narrow parting. The distinction between release testing and characterisation is one industrial documents make and retail…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #21 · Compounds › Semaglutide · 9 Jan 2025 · 2 likes Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank cloudiness are a different observation entirely…
Follow-up: Individual participant data versus aggregate data Replied, post #17 · Evidence › Meta-analyses · 8 Jan 2025 · 0 likes I came in to disagree and I am leaving without a disagreement.
Fibre intake when total intake falls, and the constipation link Replied, post #14 · Nutrition & Training › Protein & intake · 6 Jan 2025 · 32 likes Post #10 describes the usual case. This is about the unusual one. Timing of protein: spreading protein intake across the day, with some at each meal, is more practical…
Oxidation pathways for methionine and tryptophan Replied, post #3 · Analytics › Impurities & related substances · 24 Dec 2024 · 0 likes Narrowing the opening post, because the general version has more than one answer. Off-target structures: if the sequence synthesis goes wrong, a completely different…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #87 · Compounds › Semaglutide · 24 Dec 2024 · 19 likes On formulation: the licensed product is buffered and includes a preservative in the multi-dose presentation. A reconstituted research preparation matches neither, and…
Isotope patterns and why the monoisotopic peak is not the tallest Replied, post #6 · Analytics › Mass spectrometry · 13 Dec 2024 · 6 likes Post #3 is the version of this I will quote in future. One addition. If you are new and reading this thread for the answer to isotope patterns: the answer is…
Follow-up: Dead volume across syringe and needle combinations Replied, post #76 · Devices › Syringes & needles · 4 Dec 2024 · 0 likes Reusing a needle blunts it and there is no benefit to offset that. The second injection with the same needle is the one people describe as painful. That holds for the…
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #49 · Clinical › Special populations · 23 Nov 2024 · 17 likes Body weight at the extremes of the studied range affects exposure and the trials rarely reported enough to say by how much.
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #9 · Clinical › Special populations · 19 Nov 2024 · 0 likes I had written a reply contradicting post #7 and deleted it. Here is what survived. Body weight at the extremes of the studied range affects exposure and the trials…
Why "any advice?" is the least effective ending for a post Replied, post #48 · Start Here › How to Ask · 18 Nov 2024 · 12 likes Timeline questions need the timeline. Dates, in order, with what happened on each. "A while ago" and "recently" are the two least useful words in a question of this…
Revisiting: Moderation log format change Replied, post #29 · Meta › Announcements · 15 Nov 2024 · 24 likes Post #25 and I disagree about the size of the effect, not about the direction. Answering the Moderation log format change question as asked, then the question I think…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #31 · Evidence › Journal club · 13 Nov 2024 · 8 likes Adding a reference point for SURPASS-2. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted appropriately.
Time to steady state after a dose increase Replied, post #84 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 2 likes Post #80 describes the usual case. This is about the unusual one. Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is why the…
Journal club: FLOW and the renal composite, component by component Replied, post #66 · Evidence › Journal club · 15 Jul 2024 · 1 like The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. A partial…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #16 · Clinical › Prescriber conversations · 6 Jul 2024 · 0 likes Confirming post #13 from a second method, which matters more than confirming it from a second person. Written summaries after an appointment are available in many…
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #19 · Nutrition & Training › Resistance training · 27 Jun 2024 · 6 likes This is the sort of exchange that makes the archive worth searching.